The trademark MIADERMA was filed by Holland & Barrett International Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on December 14, 2021, and received one opposition filed on March 14, 2022 by LABORATOIRE HRA PHARMA on Likelihood of confusion. the opponent was represented by BAKER & MCKENZIE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 14, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on June 23, 2022.